PPARGC1A and Cognitive impairment: A recent review of the effects of PGC-1α on AD pathophysiology suggest that PGC-1α could improve oxidative stress, mitochondrial dysfunction, and insulin resistance, thereby preventing neuronal cell damage and ameliorating cognitive impairment in AD [48].